SGO: Hint of Chemoprevention Potential for Lynch Syndrome (CME/CE)

posted on Mar 16 by MedPage Today OB/Gyn in the Uncategorized category SAN FRANCISCO (MedPage Today) -- Oral contraceptives and medroxyprogesterone acetate (MPA, DepoProvera) may have potential as chemopreventive agents for endometrial cancer in women with Lynch syndrome, biomarker data from a small randomized trial suggest.